Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients
Jeremy D. Ward, Caleb Cornaby, John L. Schmitz
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 10
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2
Oscar Rosas Mejia, Erin S. Gloag, Jianying Li, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 3, pp. e1010093-e1010093
Open Access | Times Cited: 40
The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2—The results of ProBCG: a multicenter randomized clinical trial in Brazil
Ana Paula Santos, Guilherme Loureiro Werneck, Ana Paula Razal Dalvi, et al.
International Journal of Infectious Diseases (2023) Vol. 130, pp. 8-16
Open Access | Times Cited: 18
Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects
Noor Nadhim Al-Saigh, Amani A. Harb, Shtaywy Abdalla
(2024)
Open Access | Times Cited: 5
Exercise-Driven Comprehensive Recovery: Pulmonary Rehabilitation’s Impact on Lung Function, Mechanics, and Immune Response in Post-COVID-19 Patients
Maysa Alves Rodrigues Brandão-Rangel, Boris Brill, Guilherme Eustáquio Furtado, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 1-1
Open Access
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis
Petro Booysen, Katalin A. Wilkinson, Dylan Sheerin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response
Yves Renaudineau, Florence Abravanel, Jacques Izopet, et al.
Clinical Immunology (2022) Vol. 237, pp. 108979-108979
Open Access | Times Cited: 17
Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
Giuseppe Lippi, Brandon Michael Henry, Mario Plebani
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 12, pp. 1885-1888
Open Access | Times Cited: 22
In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production
Alessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo, et al.
Life (2022) Vol. 12, Iss. 2, pp. 244-244
Open Access | Times Cited: 12
Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality?
Juan J. Palacios, Azucena Rodríguez-Guardado, Miguel Arias-Guillén, et al.
Archivos de Bronconeumología (2022) Vol. 58, Iss. 9, pp. 649-659
Open Access | Times Cited: 11
Comprehensive bronchoalveolar lavage characterization in COVID-19 associated acute respiratory distress syndrome patients: a prospective cohort study
Fiorella Calabrese, Francesca Lunardi, Elisa Baldasso, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Prior COVID‐19 infection among newly diagnosed tuberculosis patients in a tertiary care center in Tehran: A case‐control study
Kiavash Semnani, Marjan Sohrabi, Parvaneh Ebrahimi Alavijeh, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 1
ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis
Binila Chacko, Dhruva Chaudhry, John Victor Peter, et al.
Indian Journal of Critical Care Medicine (2024) Vol. 28, Iss. S2, pp. S67-S91
Closed Access | Times Cited: 1
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review
Domenico Umberto De Rose, Pier Giorgio Pace, Francesca Ceccherini‐Silberstein, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 755-755
Open Access | Times Cited: 4
Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
Jane Shaw, Stephanus T. Malherbe, Gerhard Walzl, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects
Noor Nadhim Al-Saigh, Amani A. Harb, Shtaywy Abdalla
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8527-8527
Open Access | Times Cited: 1
Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update
Marilyn Urrutia‐Pereira, Herberto José Chong‐Neto, Isabella Annesi Maesano, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 9, pp. 100686-100686
Open Access | Times Cited: 7
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccine
Luis Martínez, Iker Malaina, David Salcines-Cuevas, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production
Grazia Alessio, Alessandra Imeneo, Andrea Di Lorenzo, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 6
T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants
Marta Fernández‐González, Vanesa Agulló, José Alberto García, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 9, pp. 1240-1252
Open Access | Times Cited: 3
Prevalence of indeterminate tuberculosis interferon‐gamma release assays in COVID‐19 patients: Systematic review and meta‐analysis
A. Ben Tekaya, A. Jerbi, Mouna Ben Sassi, et al.
Health Science Reports (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 3
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine
María Infantino, Aris Tsalouchos, Edda Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12333-12333
Open Access | Times Cited: 5
Enhancing the interferon-γ release assay through omission of nil and mitogen values
Yun Jung Jung, Ji Eun Park, Ji Won Park, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top